Latest News
Markwins Beauty Acquires Lorac Cosmetics Brand
Thursday 14 June 2018

14 June 2018 - US-based beauty company Markwins Beauty Brands has completed a transaction under which it will acquire the brand of Lorac Cosmetics, LLC, the company said.

This is Markwins' fourth major acquisition in fifteen years.

Markwins acquired AM Cosmetics with brands wet n wild and Black Radiance in 2003, Physicians Formula Holdings, Inc. in 2012, and Aspire Brands assets Bonne Bell and Lip Smacker in 2015.

With the addition of Lorac, Markwins will complement its already well-established mass beauty portfolio with the addition of this prestige brand.

Lorac Cosmetics was founded two decades ago by Hollywood beauty legend and PRO makeup artist Carol Shaw after she saw the need to develop products that wouldn't irritate her celebrity clients' sensitive skin.

What resulted was a line of professional, red carpet ready formulations with skin-friendly ingredients available to all. Shaw will continue to work with Markwins as lead consultant on the brand.

Rounding out its strategic portfolio of non-competing brands, Markwins adds Lorac's prestige consumer to join masstige brand Physicians Formula, entry point brand wet n wild, leading ethnic brand Black Radiance, top youth brand Lip Smacker, and its successful collection business to continue to cater to an all-inclusive consumer base.

Markwins Beauty Brands is in beauty and cosmetics.

The company, founded in 1984 by CEO Eric Sung-Tsei Chen, Markwins Beauty Brands has a brand portfolio that includes wet n wild, Physicians Formula, Black Radiance, Lip Smacker, and Bonne Bell.

It has distribution in over 80,000 doors and 80 countries.

Stifel served as financial advisor, and Latham and Watkins LLP acted as legal advisor, to Markwins on the transaction.
Date Published: 14/06/2018
Target: Lorac Cosmetics
Country: USA
Sector: Consumer Products
Type: Corporate acquisition
Status: Closed
Buyer: Markwins Beauty Brands
Buyer Advisor: Stifel , Latham and Watkins
Terms of the deal were not disclosed